Global Dalteparin Sodium Injection Supply, Demand and Key Producers, 2026-2032
The global Dalteparin Sodium Injection market size is expected to reach $ 2900 million by 2032, rising at a market growth of 6.0% CAGR during the forecast period (2026-2032).
Dalteparin Sodium Injection is a low molecular weight heparin (LMWH) anticoagulant used primarily for the prevention and treatment of thromboembolic disorders, including deep vein thrombosis (DVT) and pulmonary embolism (PE). Its mechanism of action involves enhancing the activity of antithrombin III, thereby inhibiting coagulation factor Xa and reducing the risk of blood clot formation. This medication was developed to address the limitations of conventional heparin, such as unpredictable dosing, the need for frequent coagulation monitoring, and a higher risk of bleeding.
Dalteparin Sodium was first developed and clinically introduced in the 1990s. Its low molecular weight properties provide more predictable anticoagulant effects and lower adverse risks. The manufacturing process relies on upstream raw materials such as heparin and derivative chemical reagents, while essential components like injectable vials, rubber stoppers, and needles must meet pharmaceutical-grade standards. The supply chain is tightly controlled to ensure the safety and stability of the final product.In 2025, the global production capacity of dalteparin sodium injection was 150 million boxes, with sales volume reaching 118 million boxes, an average unit price of 15.8 USD per box, and corporate gross profit margins ranging between 25% and 35%.
Currently, the market for Dalteparin Sodium Injection is experiencing steady development both globally and within domestic healthcare systems. As a key low molecular weight heparin anticoagulant, it has earned broad clinical acceptance, particularly in perioperative anticoagulation, management of venous thromboembolic disorders, and prevention of cancer-associated thrombosis. The increasing prevalence of aging populations and cardiovascular-related diseases has led to sustained demand for anticoagulant therapies that are both safe and predictable, underpinning the clinical adoption and market penetration of dalteparin. Moreover, supportive drug reimbursement policies and the push for standardized anticoagulant use in medical institutions have helped normalize its role across multidisciplinary treatment contexts. Nonetheless, the competitive landscape is intensifying, especially with the rapid adoption of novel oral anticoagulants in certain indications, creating a degree of substitution pressure that challenges the dalteparin sodium injection market.
Looking ahead, evolving clinical treatment paradigms and the promotion of individualized anticoagulation strategies are expected to raise expectations for traditional anticoagulants, emphasizing not only efficacy and safety but also patient adherence and ease of use. This environment encourages ongoing innovation in product refinement, dosing regimens, and integrated patient management services for low molecular weight heparins including dalteparin. Advances in production technology and manufacturing processes are also likely to contribute to improved product consistency and cost optimization. Furthermore, deeper exploration in life sciences research may uncover new therapeutic indications and strengthen clinical evidence for combination therapies, offering fresh opportunities for market expansion. Enhanced anticoagulation safety monitoring and improved patient treatment experiences could become significant drivers of industry growth.
Despite a positive outlook, several inhibiting factors remain. Stricter regulatory environments demand higher standards for production quality control, leading to increased R&D, regulatory submission, and compliance costs and risks for manufacturers. At the same time, intense competition from generic products and price pressures compress profit margins, particularly for innovators. Clinical challenges remain in balancing bleeding risk assessments and accounting for patient heterogeneity, necessitating more comprehensive clinical pathways and evidence-based support. Additionally, variations in how healthcare systems select and utilize anticoagulants influence the depth and breadth of dalteparin sodium injection?s adoption across different regions.
This report studies the global Dalteparin Sodium Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Dalteparin Sodium Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dalteparin Sodium Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Dalteparin Sodium Injection total production and demand, 2021-2032, (K Units)
Global Dalteparin Sodium Injection total production value, 2021-2032, (USD Million)
Global Dalteparin Sodium Injection production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Dalteparin Sodium Injection consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Dalteparin Sodium Injection domestic production, consumption, key domestic manufacturers and share
Global Dalteparin Sodium Injection production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Dalteparin Sodium Injection production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Dalteparin Sodium Injection production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Dalteparin Sodium Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Hebei Changshan Biochemical Pharmaceutical Co.,Ltd., Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd., Changzhou Qianhong Biopharma Co., Ltd., Qilu Pharmaceutical, Yantai Dongcheng Northern Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Dalteparin Sodium Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Dalteparin Sodium Injection Market, By Region:
1. How big is the global Dalteparin Sodium Injection market?
2. What is the demand of the global Dalteparin Sodium Injection market?
3. What is the year over year growth of the global Dalteparin Sodium Injection market?
4. What is the production and production value of the global Dalteparin Sodium Injection market?
5. Who are the key producers in the global Dalteparin Sodium Injection market?
6. What are the growth factors driving the market demand?
Dalteparin Sodium Injection is a low molecular weight heparin (LMWH) anticoagulant used primarily for the prevention and treatment of thromboembolic disorders, including deep vein thrombosis (DVT) and pulmonary embolism (PE). Its mechanism of action involves enhancing the activity of antithrombin III, thereby inhibiting coagulation factor Xa and reducing the risk of blood clot formation. This medication was developed to address the limitations of conventional heparin, such as unpredictable dosing, the need for frequent coagulation monitoring, and a higher risk of bleeding.
Dalteparin Sodium was first developed and clinically introduced in the 1990s. Its low molecular weight properties provide more predictable anticoagulant effects and lower adverse risks. The manufacturing process relies on upstream raw materials such as heparin and derivative chemical reagents, while essential components like injectable vials, rubber stoppers, and needles must meet pharmaceutical-grade standards. The supply chain is tightly controlled to ensure the safety and stability of the final product.In 2025, the global production capacity of dalteparin sodium injection was 150 million boxes, with sales volume reaching 118 million boxes, an average unit price of 15.8 USD per box, and corporate gross profit margins ranging between 25% and 35%.
Currently, the market for Dalteparin Sodium Injection is experiencing steady development both globally and within domestic healthcare systems. As a key low molecular weight heparin anticoagulant, it has earned broad clinical acceptance, particularly in perioperative anticoagulation, management of venous thromboembolic disorders, and prevention of cancer-associated thrombosis. The increasing prevalence of aging populations and cardiovascular-related diseases has led to sustained demand for anticoagulant therapies that are both safe and predictable, underpinning the clinical adoption and market penetration of dalteparin. Moreover, supportive drug reimbursement policies and the push for standardized anticoagulant use in medical institutions have helped normalize its role across multidisciplinary treatment contexts. Nonetheless, the competitive landscape is intensifying, especially with the rapid adoption of novel oral anticoagulants in certain indications, creating a degree of substitution pressure that challenges the dalteparin sodium injection market.
Looking ahead, evolving clinical treatment paradigms and the promotion of individualized anticoagulation strategies are expected to raise expectations for traditional anticoagulants, emphasizing not only efficacy and safety but also patient adherence and ease of use. This environment encourages ongoing innovation in product refinement, dosing regimens, and integrated patient management services for low molecular weight heparins including dalteparin. Advances in production technology and manufacturing processes are also likely to contribute to improved product consistency and cost optimization. Furthermore, deeper exploration in life sciences research may uncover new therapeutic indications and strengthen clinical evidence for combination therapies, offering fresh opportunities for market expansion. Enhanced anticoagulation safety monitoring and improved patient treatment experiences could become significant drivers of industry growth.
Despite a positive outlook, several inhibiting factors remain. Stricter regulatory environments demand higher standards for production quality control, leading to increased R&D, regulatory submission, and compliance costs and risks for manufacturers. At the same time, intense competition from generic products and price pressures compress profit margins, particularly for innovators. Clinical challenges remain in balancing bleeding risk assessments and accounting for patient heterogeneity, necessitating more comprehensive clinical pathways and evidence-based support. Additionally, variations in how healthcare systems select and utilize anticoagulants influence the depth and breadth of dalteparin sodium injection?s adoption across different regions.
This report studies the global Dalteparin Sodium Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Dalteparin Sodium Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dalteparin Sodium Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Dalteparin Sodium Injection total production and demand, 2021-2032, (K Units)
Global Dalteparin Sodium Injection total production value, 2021-2032, (USD Million)
Global Dalteparin Sodium Injection production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Dalteparin Sodium Injection consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Dalteparin Sodium Injection domestic production, consumption, key domestic manufacturers and share
Global Dalteparin Sodium Injection production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Dalteparin Sodium Injection production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Dalteparin Sodium Injection production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Dalteparin Sodium Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Hebei Changshan Biochemical Pharmaceutical Co.,Ltd., Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd., Changzhou Qianhong Biopharma Co., Ltd., Qilu Pharmaceutical, Yantai Dongcheng Northern Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Dalteparin Sodium Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Dalteparin Sodium Injection Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Dalteparin Sodium Injection 0.2ml:2500IU
- Dalteparin Sodium Injection 0.2ml:5000IU
- Dalteparin Sodium Injection 0.3ml:7500IU
- Dalteparin Sodium Injection 0.5ml:12500IU
- Dalteparin Sodium Injection 0.6ml:15000IU
- Prefilled Syringe
- Single-Dose Vial
- Porcine Intestinal Mucosa Origin
- Chemical Depolymerization
- Nitrous Acid Depolymerization
- Hospital
- Nursing Institutions
- Home Care
- Others
- Pfizer
- Hebei Changshan Biochemical Pharmaceutical Co.,Ltd.
- Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
- Changzhou Qianhong Biopharma Co., Ltd.
- Qilu Pharmaceutical
- Yantai Dongcheng Northern Pharmaceutical
1. How big is the global Dalteparin Sodium Injection market?
2. What is the demand of the global Dalteparin Sodium Injection market?
3. What is the year over year growth of the global Dalteparin Sodium Injection market?
4. What is the production and production value of the global Dalteparin Sodium Injection market?
5. Who are the key producers in the global Dalteparin Sodium Injection market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Dalteparin Sodium Injection Introduction
1.2 World Dalteparin Sodium Injection Supply & Forecast
1.2.1 World Dalteparin Sodium Injection Production Value (2021 & 2025 & 2032)
1.2.2 World Dalteparin Sodium Injection Production (2021-2032)
1.2.3 World Dalteparin Sodium Injection Pricing Trends (2021-2032)
1.3 World Dalteparin Sodium Injection Production by Region (Based on Production Site)
1.3.1 World Dalteparin Sodium Injection Production Value by Region (2021-2032)
1.3.2 World Dalteparin Sodium Injection Production by Region (2021-2032)
1.3.3 World Dalteparin Sodium Injection Average Price by Region (2021-2032)
1.3.4 North America Dalteparin Sodium Injection Production (2021-2032)
1.3.5 Europe Dalteparin Sodium Injection Production (2021-2032)
1.3.6 China Dalteparin Sodium Injection Production (2021-2032)
1.3.7 Japan Dalteparin Sodium Injection Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Dalteparin Sodium Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Dalteparin Sodium Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Dalteparin Sodium Injection Demand (2021-2032)
2.2 World Dalteparin Sodium Injection Consumption by Region
2.2.1 World Dalteparin Sodium Injection Consumption by Region (2021-2026)
2.2.2 World Dalteparin Sodium Injection Consumption Forecast by Region (2027-2032)
2.3 United States Dalteparin Sodium Injection Consumption (2021-2032)
2.4 China Dalteparin Sodium Injection Consumption (2021-2032)
2.5 Europe Dalteparin Sodium Injection Consumption (2021-2032)
2.6 Japan Dalteparin Sodium Injection Consumption (2021-2032)
2.7 South Korea Dalteparin Sodium Injection Consumption (2021-2032)
2.8 ASEAN Dalteparin Sodium Injection Consumption (2021-2032)
2.9 India Dalteparin Sodium Injection Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Dalteparin Sodium Injection Production Value by Manufacturer (2021-2026)
3.2 World Dalteparin Sodium Injection Production by Manufacturer (2021-2026)
3.3 World Dalteparin Sodium Injection Average Price by Manufacturer (2021-2026)
3.4 Dalteparin Sodium Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Dalteparin Sodium Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Dalteparin Sodium Injection in 2025
3.5.3 Global Concentration Ratios (CR8) for Dalteparin Sodium Injection in 2025
3.6 Dalteparin Sodium Injection Market: Overall Company Footprint Analysis
3.6.1 Dalteparin Sodium Injection Market: Region Footprint
3.6.2 Dalteparin Sodium Injection Market: Company Product Type Footprint
3.6.3 Dalteparin Sodium Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Dalteparin Sodium Injection Production Value Comparison
4.1.1 United States VS China: Dalteparin Sodium Injection Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Dalteparin Sodium Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Dalteparin Sodium Injection Production Comparison
4.2.1 United States VS China: Dalteparin Sodium Injection Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Dalteparin Sodium Injection Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Dalteparin Sodium Injection Consumption Comparison
4.3.1 United States VS China: Dalteparin Sodium Injection Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Dalteparin Sodium Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Dalteparin Sodium Injection Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Dalteparin Sodium Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Dalteparin Sodium Injection Production Value (2021-2026)
4.4.3 United States Based Manufacturers Dalteparin Sodium Injection Production (2021-2026)
4.5 China Based Dalteparin Sodium Injection Manufacturers and Market Share
4.5.1 China Based Dalteparin Sodium Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Dalteparin Sodium Injection Production Value (2021-2026)
4.5.3 China Based Manufacturers Dalteparin Sodium Injection Production (2021-2026)
4.6 Rest of World Based Dalteparin Sodium Injection Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Dalteparin Sodium Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Dalteparin Sodium Injection Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Dalteparin Sodium Injection Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Dalteparin Sodium Injection Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Dalteparin Sodium Injection 0.2ml:2500IU
5.2.2 Dalteparin Sodium Injection 0.2ml:5000IU
5.2.3 Dalteparin Sodium Injection 0.3ml:7500IU
5.2.4 Dalteparin Sodium Injection 0.5ml:12500IU
5.2.5 Dalteparin Sodium Injection 0.6ml:15000IU
5.3 Market Segment by Type
5.3.1 World Dalteparin Sodium Injection Production by Type (2021-2032)
5.3.2 World Dalteparin Sodium Injection Production Value by Type (2021-2032)
5.3.3 World Dalteparin Sodium Injection Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PACKAGING
6.1 World Dalteparin Sodium Injection Market Size Overview by Packaging: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Packaging
6.2.1 Prefilled Syringe
6.2.2 Single-Dose Vial
6.3 Market Segment by Packaging
6.3.1 World Dalteparin Sodium Injection Production by Packaging (2021-2032)
6.3.2 World Dalteparin Sodium Injection Production Value by Packaging (2021-2032)
6.3.3 World Dalteparin Sodium Injection Average Price by Packaging (2021-2032)
7 MARKET ANALYSIS BY MANUFACTURING PROCESS
7.1 World Dalteparin Sodium Injection Market Size Overview by Manufacturing Process: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Manufacturing Process
7.2.1 Porcine Intestinal Mucosa Origin
7.2.2 Chemical Depolymerization
7.2.3 Nitrous Acid Depolymerization
7.3 Market Segment by Manufacturing Process
7.3.1 World Dalteparin Sodium Injection Production by Manufacturing Process (2021-2032)
7.3.2 World Dalteparin Sodium Injection Production Value by Manufacturing Process (2021-2032)
7.3.3 World Dalteparin Sodium Injection Average Price by Manufacturing Process (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Dalteparin Sodium Injection Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Nursing Institutions
8.2.3 Home Care
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Dalteparin Sodium Injection Production by Application (2021-2032)
8.3.2 World Dalteparin Sodium Injection Production Value by Application (2021-2032)
8.3.3 World Dalteparin Sodium Injection Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Pfizer
9.1.1 Pfizer Details
9.1.2 Pfizer Major Business
9.1.3 Pfizer Dalteparin Sodium Injection Product and Services
9.1.4 Pfizer Dalteparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Pfizer Recent Developments/Updates
9.1.6 Pfizer Competitive Strengths & Weaknesses
9.2 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd.
9.2.1 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Details
9.2.2 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Major Business
9.2.3 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Dalteparin Sodium Injection Product and Services
9.2.4 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Dalteparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Recent Developments/Updates
9.2.6 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
9.3 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
9.3.1 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Details
9.3.2 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Major Business
9.3.3 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Dalteparin Sodium Injection Product and Services
9.3.4 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Dalteparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
9.3.6 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9.4 Changzhou Qianhong Biopharma Co., Ltd.
9.4.1 Changzhou Qianhong Biopharma Co., Ltd. Details
9.4.2 Changzhou Qianhong Biopharma Co., Ltd. Major Business
9.4.3 Changzhou Qianhong Biopharma Co., Ltd. Dalteparin Sodium Injection Product and Services
9.4.4 Changzhou Qianhong Biopharma Co., Ltd. Dalteparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Changzhou Qianhong Biopharma Co., Ltd. Recent Developments/Updates
9.4.6 Changzhou Qianhong Biopharma Co., Ltd. Competitive Strengths & Weaknesses
9.5 Qilu Pharmaceutical
9.5.1 Qilu Pharmaceutical Details
9.5.2 Qilu Pharmaceutical Major Business
9.5.3 Qilu Pharmaceutical Dalteparin Sodium Injection Product and Services
9.5.4 Qilu Pharmaceutical Dalteparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Qilu Pharmaceutical Recent Developments/Updates
9.5.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
9.6 Yantai Dongcheng Northern Pharmaceutical
9.6.1 Yantai Dongcheng Northern Pharmaceutical Details
9.6.2 Yantai Dongcheng Northern Pharmaceutical Major Business
9.6.3 Yantai Dongcheng Northern Pharmaceutical Dalteparin Sodium Injection Product and Services
9.6.4 Yantai Dongcheng Northern Pharmaceutical Dalteparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Yantai Dongcheng Northern Pharmaceutical Recent Developments/Updates
9.6.6 Yantai Dongcheng Northern Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Dalteparin Sodium Injection Industry Chain
10.2 Dalteparin Sodium Injection Upstream Analysis
10.2.1 Dalteparin Sodium Injection Core Raw Materials
10.2.2 Main Manufacturers of Dalteparin Sodium Injection Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Dalteparin Sodium Injection Production Mode
10.6 Dalteparin Sodium Injection Procurement Model
10.7 Dalteparin Sodium Injection Industry Sales Model and Sales Channels
10.7.1 Dalteparin Sodium Injection Sales Model
10.7.2 Dalteparin Sodium Injection Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Dalteparin Sodium Injection Introduction
1.2 World Dalteparin Sodium Injection Supply & Forecast
1.2.1 World Dalteparin Sodium Injection Production Value (2021 & 2025 & 2032)
1.2.2 World Dalteparin Sodium Injection Production (2021-2032)
1.2.3 World Dalteparin Sodium Injection Pricing Trends (2021-2032)
1.3 World Dalteparin Sodium Injection Production by Region (Based on Production Site)
1.3.1 World Dalteparin Sodium Injection Production Value by Region (2021-2032)
1.3.2 World Dalteparin Sodium Injection Production by Region (2021-2032)
1.3.3 World Dalteparin Sodium Injection Average Price by Region (2021-2032)
1.3.4 North America Dalteparin Sodium Injection Production (2021-2032)
1.3.5 Europe Dalteparin Sodium Injection Production (2021-2032)
1.3.6 China Dalteparin Sodium Injection Production (2021-2032)
1.3.7 Japan Dalteparin Sodium Injection Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Dalteparin Sodium Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Dalteparin Sodium Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Dalteparin Sodium Injection Demand (2021-2032)
2.2 World Dalteparin Sodium Injection Consumption by Region
2.2.1 World Dalteparin Sodium Injection Consumption by Region (2021-2026)
2.2.2 World Dalteparin Sodium Injection Consumption Forecast by Region (2027-2032)
2.3 United States Dalteparin Sodium Injection Consumption (2021-2032)
2.4 China Dalteparin Sodium Injection Consumption (2021-2032)
2.5 Europe Dalteparin Sodium Injection Consumption (2021-2032)
2.6 Japan Dalteparin Sodium Injection Consumption (2021-2032)
2.7 South Korea Dalteparin Sodium Injection Consumption (2021-2032)
2.8 ASEAN Dalteparin Sodium Injection Consumption (2021-2032)
2.9 India Dalteparin Sodium Injection Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Dalteparin Sodium Injection Production Value by Manufacturer (2021-2026)
3.2 World Dalteparin Sodium Injection Production by Manufacturer (2021-2026)
3.3 World Dalteparin Sodium Injection Average Price by Manufacturer (2021-2026)
3.4 Dalteparin Sodium Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Dalteparin Sodium Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Dalteparin Sodium Injection in 2025
3.5.3 Global Concentration Ratios (CR8) for Dalteparin Sodium Injection in 2025
3.6 Dalteparin Sodium Injection Market: Overall Company Footprint Analysis
3.6.1 Dalteparin Sodium Injection Market: Region Footprint
3.6.2 Dalteparin Sodium Injection Market: Company Product Type Footprint
3.6.3 Dalteparin Sodium Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Dalteparin Sodium Injection Production Value Comparison
4.1.1 United States VS China: Dalteparin Sodium Injection Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Dalteparin Sodium Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Dalteparin Sodium Injection Production Comparison
4.2.1 United States VS China: Dalteparin Sodium Injection Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Dalteparin Sodium Injection Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Dalteparin Sodium Injection Consumption Comparison
4.3.1 United States VS China: Dalteparin Sodium Injection Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Dalteparin Sodium Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Dalteparin Sodium Injection Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Dalteparin Sodium Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Dalteparin Sodium Injection Production Value (2021-2026)
4.4.3 United States Based Manufacturers Dalteparin Sodium Injection Production (2021-2026)
4.5 China Based Dalteparin Sodium Injection Manufacturers and Market Share
4.5.1 China Based Dalteparin Sodium Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Dalteparin Sodium Injection Production Value (2021-2026)
4.5.3 China Based Manufacturers Dalteparin Sodium Injection Production (2021-2026)
4.6 Rest of World Based Dalteparin Sodium Injection Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Dalteparin Sodium Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Dalteparin Sodium Injection Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Dalteparin Sodium Injection Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Dalteparin Sodium Injection Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Dalteparin Sodium Injection 0.2ml:2500IU
5.2.2 Dalteparin Sodium Injection 0.2ml:5000IU
5.2.3 Dalteparin Sodium Injection 0.3ml:7500IU
5.2.4 Dalteparin Sodium Injection 0.5ml:12500IU
5.2.5 Dalteparin Sodium Injection 0.6ml:15000IU
5.3 Market Segment by Type
5.3.1 World Dalteparin Sodium Injection Production by Type (2021-2032)
5.3.2 World Dalteparin Sodium Injection Production Value by Type (2021-2032)
5.3.3 World Dalteparin Sodium Injection Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY PACKAGING
6.1 World Dalteparin Sodium Injection Market Size Overview by Packaging: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Packaging
6.2.1 Prefilled Syringe
6.2.2 Single-Dose Vial
6.3 Market Segment by Packaging
6.3.1 World Dalteparin Sodium Injection Production by Packaging (2021-2032)
6.3.2 World Dalteparin Sodium Injection Production Value by Packaging (2021-2032)
6.3.3 World Dalteparin Sodium Injection Average Price by Packaging (2021-2032)
7 MARKET ANALYSIS BY MANUFACTURING PROCESS
7.1 World Dalteparin Sodium Injection Market Size Overview by Manufacturing Process: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Manufacturing Process
7.2.1 Porcine Intestinal Mucosa Origin
7.2.2 Chemical Depolymerization
7.2.3 Nitrous Acid Depolymerization
7.3 Market Segment by Manufacturing Process
7.3.1 World Dalteparin Sodium Injection Production by Manufacturing Process (2021-2032)
7.3.2 World Dalteparin Sodium Injection Production Value by Manufacturing Process (2021-2032)
7.3.3 World Dalteparin Sodium Injection Average Price by Manufacturing Process (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Dalteparin Sodium Injection Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Nursing Institutions
8.2.3 Home Care
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Dalteparin Sodium Injection Production by Application (2021-2032)
8.3.2 World Dalteparin Sodium Injection Production Value by Application (2021-2032)
8.3.3 World Dalteparin Sodium Injection Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Pfizer
9.1.1 Pfizer Details
9.1.2 Pfizer Major Business
9.1.3 Pfizer Dalteparin Sodium Injection Product and Services
9.1.4 Pfizer Dalteparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Pfizer Recent Developments/Updates
9.1.6 Pfizer Competitive Strengths & Weaknesses
9.2 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd.
9.2.1 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Details
9.2.2 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Major Business
9.2.3 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Dalteparin Sodium Injection Product and Services
9.2.4 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Dalteparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Recent Developments/Updates
9.2.6 Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
9.3 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
9.3.1 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Details
9.3.2 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Major Business
9.3.3 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Dalteparin Sodium Injection Product and Services
9.3.4 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Dalteparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
9.3.6 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
9.4 Changzhou Qianhong Biopharma Co., Ltd.
9.4.1 Changzhou Qianhong Biopharma Co., Ltd. Details
9.4.2 Changzhou Qianhong Biopharma Co., Ltd. Major Business
9.4.3 Changzhou Qianhong Biopharma Co., Ltd. Dalteparin Sodium Injection Product and Services
9.4.4 Changzhou Qianhong Biopharma Co., Ltd. Dalteparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Changzhou Qianhong Biopharma Co., Ltd. Recent Developments/Updates
9.4.6 Changzhou Qianhong Biopharma Co., Ltd. Competitive Strengths & Weaknesses
9.5 Qilu Pharmaceutical
9.5.1 Qilu Pharmaceutical Details
9.5.2 Qilu Pharmaceutical Major Business
9.5.3 Qilu Pharmaceutical Dalteparin Sodium Injection Product and Services
9.5.4 Qilu Pharmaceutical Dalteparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Qilu Pharmaceutical Recent Developments/Updates
9.5.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
9.6 Yantai Dongcheng Northern Pharmaceutical
9.6.1 Yantai Dongcheng Northern Pharmaceutical Details
9.6.2 Yantai Dongcheng Northern Pharmaceutical Major Business
9.6.3 Yantai Dongcheng Northern Pharmaceutical Dalteparin Sodium Injection Product and Services
9.6.4 Yantai Dongcheng Northern Pharmaceutical Dalteparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Yantai Dongcheng Northern Pharmaceutical Recent Developments/Updates
9.6.6 Yantai Dongcheng Northern Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Dalteparin Sodium Injection Industry Chain
10.2 Dalteparin Sodium Injection Upstream Analysis
10.2.1 Dalteparin Sodium Injection Core Raw Materials
10.2.2 Main Manufacturers of Dalteparin Sodium Injection Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Dalteparin Sodium Injection Production Mode
10.6 Dalteparin Sodium Injection Procurement Model
10.7 Dalteparin Sodium Injection Industry Sales Model and Sales Channels
10.7.1 Dalteparin Sodium Injection Sales Model
10.7.2 Dalteparin Sodium Injection Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Dalteparin Sodium Injection Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Dalteparin Sodium Injection Production Value by Region (2021-2026) & (USD Million)
Table 3. World Dalteparin Sodium Injection Production Value by Region (2027-2032) & (USD Million)
Table 4. World Dalteparin Sodium Injection Production Value Market Share by Region (2021-2026)
Table 5. World Dalteparin Sodium Injection Production Value Market Share by Region (2027-2032)
Table 6. World Dalteparin Sodium Injection Production by Region (2021-2026) & (K Units)
Table 7. World Dalteparin Sodium Injection Production by Region (2027-2032) & (K Units)
Table 8. World Dalteparin Sodium Injection Production Market Share by Region (2021-2026)
Table 9. World Dalteparin Sodium Injection Production Market Share by Region (2027-2032)
Table 10. World Dalteparin Sodium Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Dalteparin Sodium Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Dalteparin Sodium Injection Major Market Trends
Table 13. World Dalteparin Sodium Injection Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Dalteparin Sodium Injection Consumption by Region (2021-2026) & (K Units)
Table 15. World Dalteparin Sodium Injection Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Dalteparin Sodium Injection Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Dalteparin Sodium Injection Producers in 2025
Table 18. World Dalteparin Sodium Injection Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Dalteparin Sodium Injection Producers in 2025
Table 20. World Dalteparin Sodium Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Dalteparin Sodium Injection Company Evaluation Quadrant
Table 22. World Dalteparin Sodium Injection Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Dalteparin Sodium Injection Production Site of Key Manufacturer
Table 24. Dalteparin Sodium Injection Market: Company Product Type Footprint
Table 25. Dalteparin Sodium Injection Market: Company Product Application Footprint
Table 26. Dalteparin Sodium Injection Competitive Factors
Table 27. Dalteparin Sodium Injection New Entrant and Capacity Expansion Plans
Table 28. Dalteparin Sodium Injection Mergers & Acquisitions Activity
Table 29. United States VS China Dalteparin Sodium Injection Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Dalteparin Sodium Injection Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Dalteparin Sodium Injection Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Dalteparin Sodium Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Dalteparin Sodium Injection Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Dalteparin Sodium Injection Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Dalteparin Sodium Injection Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Dalteparin Sodium Injection Production Market Share (2021-2026)
Table 37. China Based Dalteparin Sodium Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Dalteparin Sodium Injection Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Dalteparin Sodium Injection Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Dalteparin Sodium Injection Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Dalteparin Sodium Injection Production Market Share (2021-2026)
Table 42. Rest of World Based Dalteparin Sodium Injection Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Dalteparin Sodium Injection Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Dalteparin Sodium Injection Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Dalteparin Sodium Injection Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Dalteparin Sodium Injection Production Market Share (2021-2026)
Table 47. World Dalteparin Sodium Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Dalteparin Sodium Injection Production by Type (2021-2026) & (K Units)
Table 49. World Dalteparin Sodium Injection Production by Type (2027-2032) & (K Units)
Table 50. World Dalteparin Sodium Injection Production Value by Type (2021-2026) & (USD Million)
Table 51. World Dalteparin Sodium Injection Production Value by Type (2027-2032) & (USD Million)
Table 52. World Dalteparin Sodium Injection Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Dalteparin Sodium Injection Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Dalteparin Sodium Injection Production Value by Packaging, (USD Million), 2021 & 2025 & 2032
Table 55. World Dalteparin Sodium Injection Production by Packaging (2021-2026) & (K Units)
Table 56. World Dalteparin Sodium Injection Production by Packaging (2027-2032) & (K Units)
Table 57. World Dalteparin Sodium Injection Production Value by Packaging (2021-2026) & (USD Million)
Table 58. World Dalteparin Sodium Injection Production Value by Packaging (2027-2032) & (USD Million)
Table 59. World Dalteparin Sodium Injection Average Price by Packaging (2021-2026) & (US$/Unit)
Table 60. World Dalteparin Sodium Injection Average Price by Packaging (2027-2032) & (US$/Unit)
Table 61. World Dalteparin Sodium Injection Production Value by Manufacturing Process, (USD Million), 2021 & 2025 & 2032
Table 62. World Dalteparin Sodium Injection Production by Manufacturing Process (2021-2026) & (K Units)
Table 63. World Dalteparin Sodium Injection Production by Manufacturing Process (2027-2032) & (K Units)
Table 64. World Dalteparin Sodium Injection Production Value by Manufacturing Process (2021-2026) & (USD Million)
Table 65. World Dalteparin Sodium Injection Production Value by Manufacturing Process (2027-2032) & (USD Million)
Table 66. World Dalteparin Sodium Injection Average Price by Manufacturing Process (2021-2026) & (US$/Unit)
Table 67. World Dalteparin Sodium Injection Average Price by Manufacturing Process (2027-2032) & (US$/Unit)
Table 68. World Dalteparin Sodium Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Dalteparin Sodium Injection Production by Application (2021-2026) & (K Units)
Table 70. World Dalteparin Sodium Injection Production by Application (2027-2032) & (K Units)
Table 71. World Dalteparin Sodium Injection Production Value by Application (2021-2026) & (USD Million)
Table 72. World Dalteparin Sodium Injection Production Value by Application (2027-2032) & (USD Million)
Table 73. World Dalteparin Sodium Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Dalteparin Sodium Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Pfizer Basic Information, Manufacturing Base and Competitors
Table 76. Pfizer Major Business
Table 77. Pfizer Dalteparin Sodium Injection Product and Services
Table 78. Pfizer Dalteparin Sodium Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Pfizer Recent Developments/Updates
Table 80. Pfizer Competitive Strengths & Weaknesses
Table 81. Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 82. Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Major Business
Table 83. Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Dalteparin Sodium Injection Product and Services
Table 84. Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Dalteparin Sodium Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 86. Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
Table 87. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 88. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Major Business
Table 89. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Dalteparin Sodium Injection Product and Services
Table 90. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Dalteparin Sodium Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 92. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 93. Changzhou Qianhong Biopharma Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 94. Changzhou Qianhong Biopharma Co., Ltd. Major Business
Table 95. Changzhou Qianhong Biopharma Co., Ltd. Dalteparin Sodium Injection Product and Services
Table 96. Changzhou Qianhong Biopharma Co., Ltd. Dalteparin Sodium Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Changzhou Qianhong Biopharma Co., Ltd. Recent Developments/Updates
Table 98. Changzhou Qianhong Biopharma Co., Ltd. Competitive Strengths & Weaknesses
Table 99. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 100. Qilu Pharmaceutical Major Business
Table 101. Qilu Pharmaceutical Dalteparin Sodium Injection Product and Services
Table 102. Qilu Pharmaceutical Dalteparin Sodium Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Qilu Pharmaceutical Recent Developments/Updates
Table 104. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 105. Yantai Dongcheng Northern Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 106. Yantai Dongcheng Northern Pharmaceutical Major Business
Table 107. Yantai Dongcheng Northern Pharmaceutical Dalteparin Sodium Injection Product and Services
Table 108. Yantai Dongcheng Northern Pharmaceutical Dalteparin Sodium Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Yantai Dongcheng Northern Pharmaceutical Recent Developments/Updates
Table 110. Yantai Dongcheng Northern Pharmaceutical Competitive Strengths & Weaknesses
Table 111. Global Key Players of Dalteparin Sodium Injection Upstream (Raw Materials)
Table 112. Global Dalteparin Sodium Injection Typical Customers
Table 113. Dalteparin Sodium Injection Typical Distributors
Table 1. World Dalteparin Sodium Injection Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Dalteparin Sodium Injection Production Value by Region (2021-2026) & (USD Million)
Table 3. World Dalteparin Sodium Injection Production Value by Region (2027-2032) & (USD Million)
Table 4. World Dalteparin Sodium Injection Production Value Market Share by Region (2021-2026)
Table 5. World Dalteparin Sodium Injection Production Value Market Share by Region (2027-2032)
Table 6. World Dalteparin Sodium Injection Production by Region (2021-2026) & (K Units)
Table 7. World Dalteparin Sodium Injection Production by Region (2027-2032) & (K Units)
Table 8. World Dalteparin Sodium Injection Production Market Share by Region (2021-2026)
Table 9. World Dalteparin Sodium Injection Production Market Share by Region (2027-2032)
Table 10. World Dalteparin Sodium Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Dalteparin Sodium Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Dalteparin Sodium Injection Major Market Trends
Table 13. World Dalteparin Sodium Injection Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Dalteparin Sodium Injection Consumption by Region (2021-2026) & (K Units)
Table 15. World Dalteparin Sodium Injection Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Dalteparin Sodium Injection Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Dalteparin Sodium Injection Producers in 2025
Table 18. World Dalteparin Sodium Injection Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Dalteparin Sodium Injection Producers in 2025
Table 20. World Dalteparin Sodium Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Dalteparin Sodium Injection Company Evaluation Quadrant
Table 22. World Dalteparin Sodium Injection Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Dalteparin Sodium Injection Production Site of Key Manufacturer
Table 24. Dalteparin Sodium Injection Market: Company Product Type Footprint
Table 25. Dalteparin Sodium Injection Market: Company Product Application Footprint
Table 26. Dalteparin Sodium Injection Competitive Factors
Table 27. Dalteparin Sodium Injection New Entrant and Capacity Expansion Plans
Table 28. Dalteparin Sodium Injection Mergers & Acquisitions Activity
Table 29. United States VS China Dalteparin Sodium Injection Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Dalteparin Sodium Injection Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Dalteparin Sodium Injection Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Dalteparin Sodium Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Dalteparin Sodium Injection Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Dalteparin Sodium Injection Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Dalteparin Sodium Injection Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Dalteparin Sodium Injection Production Market Share (2021-2026)
Table 37. China Based Dalteparin Sodium Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Dalteparin Sodium Injection Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Dalteparin Sodium Injection Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Dalteparin Sodium Injection Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Dalteparin Sodium Injection Production Market Share (2021-2026)
Table 42. Rest of World Based Dalteparin Sodium Injection Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Dalteparin Sodium Injection Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Dalteparin Sodium Injection Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Dalteparin Sodium Injection Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Dalteparin Sodium Injection Production Market Share (2021-2026)
Table 47. World Dalteparin Sodium Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Dalteparin Sodium Injection Production by Type (2021-2026) & (K Units)
Table 49. World Dalteparin Sodium Injection Production by Type (2027-2032) & (K Units)
Table 50. World Dalteparin Sodium Injection Production Value by Type (2021-2026) & (USD Million)
Table 51. World Dalteparin Sodium Injection Production Value by Type (2027-2032) & (USD Million)
Table 52. World Dalteparin Sodium Injection Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Dalteparin Sodium Injection Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Dalteparin Sodium Injection Production Value by Packaging, (USD Million), 2021 & 2025 & 2032
Table 55. World Dalteparin Sodium Injection Production by Packaging (2021-2026) & (K Units)
Table 56. World Dalteparin Sodium Injection Production by Packaging (2027-2032) & (K Units)
Table 57. World Dalteparin Sodium Injection Production Value by Packaging (2021-2026) & (USD Million)
Table 58. World Dalteparin Sodium Injection Production Value by Packaging (2027-2032) & (USD Million)
Table 59. World Dalteparin Sodium Injection Average Price by Packaging (2021-2026) & (US$/Unit)
Table 60. World Dalteparin Sodium Injection Average Price by Packaging (2027-2032) & (US$/Unit)
Table 61. World Dalteparin Sodium Injection Production Value by Manufacturing Process, (USD Million), 2021 & 2025 & 2032
Table 62. World Dalteparin Sodium Injection Production by Manufacturing Process (2021-2026) & (K Units)
Table 63. World Dalteparin Sodium Injection Production by Manufacturing Process (2027-2032) & (K Units)
Table 64. World Dalteparin Sodium Injection Production Value by Manufacturing Process (2021-2026) & (USD Million)
Table 65. World Dalteparin Sodium Injection Production Value by Manufacturing Process (2027-2032) & (USD Million)
Table 66. World Dalteparin Sodium Injection Average Price by Manufacturing Process (2021-2026) & (US$/Unit)
Table 67. World Dalteparin Sodium Injection Average Price by Manufacturing Process (2027-2032) & (US$/Unit)
Table 68. World Dalteparin Sodium Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Dalteparin Sodium Injection Production by Application (2021-2026) & (K Units)
Table 70. World Dalteparin Sodium Injection Production by Application (2027-2032) & (K Units)
Table 71. World Dalteparin Sodium Injection Production Value by Application (2021-2026) & (USD Million)
Table 72. World Dalteparin Sodium Injection Production Value by Application (2027-2032) & (USD Million)
Table 73. World Dalteparin Sodium Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Dalteparin Sodium Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Pfizer Basic Information, Manufacturing Base and Competitors
Table 76. Pfizer Major Business
Table 77. Pfizer Dalteparin Sodium Injection Product and Services
Table 78. Pfizer Dalteparin Sodium Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Pfizer Recent Developments/Updates
Table 80. Pfizer Competitive Strengths & Weaknesses
Table 81. Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 82. Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Major Business
Table 83. Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Dalteparin Sodium Injection Product and Services
Table 84. Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Dalteparin Sodium Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 86. Hebei Changshan Biochemical Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
Table 87. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 88. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Major Business
Table 89. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Dalteparin Sodium Injection Product and Services
Table 90. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Dalteparin Sodium Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 92. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 93. Changzhou Qianhong Biopharma Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 94. Changzhou Qianhong Biopharma Co., Ltd. Major Business
Table 95. Changzhou Qianhong Biopharma Co., Ltd. Dalteparin Sodium Injection Product and Services
Table 96. Changzhou Qianhong Biopharma Co., Ltd. Dalteparin Sodium Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Changzhou Qianhong Biopharma Co., Ltd. Recent Developments/Updates
Table 98. Changzhou Qianhong Biopharma Co., Ltd. Competitive Strengths & Weaknesses
Table 99. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 100. Qilu Pharmaceutical Major Business
Table 101. Qilu Pharmaceutical Dalteparin Sodium Injection Product and Services
Table 102. Qilu Pharmaceutical Dalteparin Sodium Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Qilu Pharmaceutical Recent Developments/Updates
Table 104. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 105. Yantai Dongcheng Northern Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 106. Yantai Dongcheng Northern Pharmaceutical Major Business
Table 107. Yantai Dongcheng Northern Pharmaceutical Dalteparin Sodium Injection Product and Services
Table 108. Yantai Dongcheng Northern Pharmaceutical Dalteparin Sodium Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Yantai Dongcheng Northern Pharmaceutical Recent Developments/Updates
Table 110. Yantai Dongcheng Northern Pharmaceutical Competitive Strengths & Weaknesses
Table 111. Global Key Players of Dalteparin Sodium Injection Upstream (Raw Materials)
Table 112. Global Dalteparin Sodium Injection Typical Customers
Table 113. Dalteparin Sodium Injection Typical Distributors
LIST OF FIGURES
Figure 1. Dalteparin Sodium Injection Picture
Figure 2. World Dalteparin Sodium Injection Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Dalteparin Sodium Injection Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Dalteparin Sodium Injection Production (2021-2032) & (K Units)
Figure 5. World Dalteparin Sodium Injection Average Price (2021-2032) & (US$/Unit)
Figure 6. World Dalteparin Sodium Injection Production Value Market Share by Region (2021-2032)
Figure 7. World Dalteparin Sodium Injection Production Market Share by Region (2021-2032)
Figure 8. North America Dalteparin Sodium Injection Production (2021-2032) & (K Units)
Figure 9. Europe Dalteparin Sodium Injection Production (2021-2032) & (K Units)
Figure 10. China Dalteparin Sodium Injection Production (2021-2032) & (K Units)
Figure 11. Japan Dalteparin Sodium Injection Production (2021-2032) & (K Units)
Figure 12. Dalteparin Sodium Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Dalteparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 15. World Dalteparin Sodium Injection Consumption Market Share by Region (2021-2032)
Figure 16. United States Dalteparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 17. China Dalteparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 18. Europe Dalteparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 19. Japan Dalteparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 20. South Korea Dalteparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Dalteparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 22. India Dalteparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Dalteparin Sodium Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Dalteparin Sodium Injection Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Dalteparin Sodium Injection Markets in 2025
Figure 26. United States VS China: Dalteparin Sodium Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Dalteparin Sodium Injection Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Dalteparin Sodium Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Dalteparin Sodium Injection Production Market Share 2025
Figure 30. China Based Manufacturers Dalteparin Sodium Injection Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Dalteparin Sodium Injection Production Market Share 2025
Figure 32. World Dalteparin Sodium Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Dalteparin Sodium Injection Production Value Market Share by Type in 2025
Figure 34. Dalteparin Sodium Injection 0.2ml:2500IU
Figure 35. Dalteparin Sodium Injection 0.2ml:5000IU
Figure 36. Dalteparin Sodium Injection 0.3ml:7500IU
Figure 37. Dalteparin Sodium Injection 0.5ml:12500IU
Figure 38. Dalteparin Sodium Injection 0.6ml:15000IU
Figure 39. World Dalteparin Sodium Injection Production Market Share by Type (2021-2032)
Figure 40. World Dalteparin Sodium Injection Production Value Market Share by Type (2021-2032)
Figure 41. World Dalteparin Sodium Injection Average Price by Type (2021-2032) & (US$/Unit)
Figure 42. World Dalteparin Sodium Injection Production Value by Packaging, (USD Million), 2021 & 2025 & 2032
Figure 43. World Dalteparin Sodium Injection Production Value Market Share by Packaging in 2025
Figure 44. Prefilled Syringe
Figure 45. Single-Dose Vial
Figure 46. World Dalteparin Sodium Injection Production Market Share by Packaging (2021-2032)
Figure 47. World Dalteparin Sodium Injection Production Value Market Share by Packaging (2021-2032)
Figure 48. World Dalteparin Sodium Injection Average Price by Packaging (2021-2032) & (US$/Unit)
Figure 49. World Dalteparin Sodium Injection Production Value by Manufacturing Process, (USD Million), 2021 & 2025 & 2032
Figure 50. World Dalteparin Sodium Injection Production Value Market Share by Manufacturing Process in 2025
Figure 51. Porcine Intestinal Mucosa Origin
Figure 52. Chemical Depolymerization
Figure 53. Nitrous Acid Depolymerization
Figure 54. World Dalteparin Sodium Injection Production Market Share by Manufacturing Process (2021-2032)
Figure 55. World Dalteparin Sodium Injection Production Value Market Share by Manufacturing Process (2021-2032)
Figure 56. World Dalteparin Sodium Injection Average Price by Manufacturing Process (2021-2032) & (US$/Unit)
Figure 57. World Dalteparin Sodium Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World Dalteparin Sodium Injection Production Value Market Share by Application in 2025
Figure 59. Hospital
Figure 60. Nursing Institutions
Figure 61. Home Care
Figure 62. Others
Figure 63. World Dalteparin Sodium Injection Production Market Share by Application (2021-2032)
Figure 64. World Dalteparin Sodium Injection Production Value Market Share by Application (2021-2032)
Figure 65. World Dalteparin Sodium Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 66. Dalteparin Sodium Injection Industry Chain
Figure 67. Dalteparin Sodium Injection Procurement Model
Figure 68. Dalteparin Sodium Injection Sales Model
Figure 69. Dalteparin Sodium Injection Sales Channels, Direct Sales, and Distribution
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Dalteparin Sodium Injection Picture
Figure 2. World Dalteparin Sodium Injection Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Dalteparin Sodium Injection Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Dalteparin Sodium Injection Production (2021-2032) & (K Units)
Figure 5. World Dalteparin Sodium Injection Average Price (2021-2032) & (US$/Unit)
Figure 6. World Dalteparin Sodium Injection Production Value Market Share by Region (2021-2032)
Figure 7. World Dalteparin Sodium Injection Production Market Share by Region (2021-2032)
Figure 8. North America Dalteparin Sodium Injection Production (2021-2032) & (K Units)
Figure 9. Europe Dalteparin Sodium Injection Production (2021-2032) & (K Units)
Figure 10. China Dalteparin Sodium Injection Production (2021-2032) & (K Units)
Figure 11. Japan Dalteparin Sodium Injection Production (2021-2032) & (K Units)
Figure 12. Dalteparin Sodium Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Dalteparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 15. World Dalteparin Sodium Injection Consumption Market Share by Region (2021-2032)
Figure 16. United States Dalteparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 17. China Dalteparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 18. Europe Dalteparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 19. Japan Dalteparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 20. South Korea Dalteparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Dalteparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 22. India Dalteparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Dalteparin Sodium Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Dalteparin Sodium Injection Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Dalteparin Sodium Injection Markets in 2025
Figure 26. United States VS China: Dalteparin Sodium Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Dalteparin Sodium Injection Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Dalteparin Sodium Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Dalteparin Sodium Injection Production Market Share 2025
Figure 30. China Based Manufacturers Dalteparin Sodium Injection Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Dalteparin Sodium Injection Production Market Share 2025
Figure 32. World Dalteparin Sodium Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Dalteparin Sodium Injection Production Value Market Share by Type in 2025
Figure 34. Dalteparin Sodium Injection 0.2ml:2500IU
Figure 35. Dalteparin Sodium Injection 0.2ml:5000IU
Figure 36. Dalteparin Sodium Injection 0.3ml:7500IU
Figure 37. Dalteparin Sodium Injection 0.5ml:12500IU
Figure 38. Dalteparin Sodium Injection 0.6ml:15000IU
Figure 39. World Dalteparin Sodium Injection Production Market Share by Type (2021-2032)
Figure 40. World Dalteparin Sodium Injection Production Value Market Share by Type (2021-2032)
Figure 41. World Dalteparin Sodium Injection Average Price by Type (2021-2032) & (US$/Unit)
Figure 42. World Dalteparin Sodium Injection Production Value by Packaging, (USD Million), 2021 & 2025 & 2032
Figure 43. World Dalteparin Sodium Injection Production Value Market Share by Packaging in 2025
Figure 44. Prefilled Syringe
Figure 45. Single-Dose Vial
Figure 46. World Dalteparin Sodium Injection Production Market Share by Packaging (2021-2032)
Figure 47. World Dalteparin Sodium Injection Production Value Market Share by Packaging (2021-2032)
Figure 48. World Dalteparin Sodium Injection Average Price by Packaging (2021-2032) & (US$/Unit)
Figure 49. World Dalteparin Sodium Injection Production Value by Manufacturing Process, (USD Million), 2021 & 2025 & 2032
Figure 50. World Dalteparin Sodium Injection Production Value Market Share by Manufacturing Process in 2025
Figure 51. Porcine Intestinal Mucosa Origin
Figure 52. Chemical Depolymerization
Figure 53. Nitrous Acid Depolymerization
Figure 54. World Dalteparin Sodium Injection Production Market Share by Manufacturing Process (2021-2032)
Figure 55. World Dalteparin Sodium Injection Production Value Market Share by Manufacturing Process (2021-2032)
Figure 56. World Dalteparin Sodium Injection Average Price by Manufacturing Process (2021-2032) & (US$/Unit)
Figure 57. World Dalteparin Sodium Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World Dalteparin Sodium Injection Production Value Market Share by Application in 2025
Figure 59. Hospital
Figure 60. Nursing Institutions
Figure 61. Home Care
Figure 62. Others
Figure 63. World Dalteparin Sodium Injection Production Market Share by Application (2021-2032)
Figure 64. World Dalteparin Sodium Injection Production Value Market Share by Application (2021-2032)
Figure 65. World Dalteparin Sodium Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 66. Dalteparin Sodium Injection Industry Chain
Figure 67. Dalteparin Sodium Injection Procurement Model
Figure 68. Dalteparin Sodium Injection Sales Model
Figure 69. Dalteparin Sodium Injection Sales Channels, Direct Sales, and Distribution
Figure 70. Methodology
Figure 71. Research Process and Data Source
